Drugs / Adenovirus-transfected DC + CIK
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT01898663 | Jun 2013 → Dec 2024 | soft tissue sarcoma | Affiliated Hospital to Academy of Military Medical Sciences | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Adenovirus-transfected DC + CIK | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01898663 ↗ |
| Known as | cytokine-induced killer (CIK) cells | “cytokine-induced killer (CIK) cells” NCT01898663 ↗ |